(19)
(11) EP 1 074 625 A3

(12) EUROPEAN PATENT APPLICATION

(88) Date of publication A3:
02.01.2002 Bulletin 2002/01

(43) Date of publication A2:
07.02.2001 Bulletin 2001/06

(21) Application number: 00304924.4

(22) Date of filing: 09.06.2000
(51) International Patent Classification (IPC)7C12N 15/49, A61K 39/21, A61K 48/00, C07K 16/10, A61P 31/14
// C07K14/155
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 14.06.1999 US 138999 P

(71) Applicant: Pfizer Products Inc.
Groton, Connecticut 06340 (US)

(72) Inventors:
  • Deng, Ruitang
    Groton, Connecticut 06340 (US)
  • Jeevarathnam, Suresh
    Groton, Connecticut 06340 (US)
  • Fuog, Eric Douglas
    Groton, Connecticut 06340 (US)
  • Koertje, William Dee
    Groton, Connecticut 06340 (US)
  • Johnson, Anthony Fay
    Groton, Connecticut 06340 (US)
  • Sheppard, Michael George
    Groton, Connecticut 06340 (US)
  • Yule, Terecita Dolores
    Groton, Connecticut 06340 (US)
  • Roth, Mark Brian
    Groton, Connecticut 06340 (US)
  • Wheeler, David Walter
    Groton, Connecticut 06340 (US)

(74) Representative: Simpson, Alison Elizabeth Fraser et al
Urquhart-Dykes & Lord, 30 Welbeck Street
London W1G 8ER
London W1G 8ER (GB)

   


(54) DNA vaccine against feline immunodeficiency virus


(57) The present invention is directed to vaccine compositions that can be used to protect cats against feline immunodeficiency virus. More particularly, the present invention relates to polynucleotide molecules that can be used as vaccine components against feline immunodeficiency virus.







Search report